CLL
Clinical trials for CLL explained in plain language.
Never miss a new study
Get alerted when new CLL trials appear
Sign up with your email to follow new studies for CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to help leukemia patients stop treatment
Disease control Recruiting nowThis study is testing whether adding a drug called epcoritamab to standard treatment can help patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) achieve a deeper remission. The goal is to see if this combination can eliminate nearly all cancer ce…
Matched conditions: CLL
Phase: PHASE2 • Sponsor: Zulfa Omer • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for Tough-to-Treat blood cancer: major trial tests promising drug duo
Disease control Recruiting nowThis study is for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has returned or stopped responding to at least one prior treatment. It aims to see if a new combination of two drugs, nemtabrutinib and venetoclax, works better and is as saf…
Matched conditions: CLL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for Tough-to-Treat blood cancer patients
Disease control Recruiting nowThis study is testing a new drug called BGB-16673 for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose cancer has come back or stopped responding after two common types of targeted therapies. About 250 participants worldwide will be randoml…
Matched conditions: CLL
Phase: PHASE3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Massive 8,000-Patient study tracks rare blood cancers for decades
Knowledge-focused Recruiting nowThis study is creating a long-term registry to track 8,000 patients with several rare types of leukemia and lymphoma. It aims to collect health information over many years to understand how these diseases progress, how treatments affect long-term survival, and what late side effe…
Matched conditions: CLL
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC